|
Marshall Medical Center South Boaz, AL 35957 CMS Certification Number: 010005 |
Free Profile
Identification and Characteristics
- Last updated 06/28/2022 / Definitions
![]()
Compare Profile information with national averages or designated peer groups.
More Information | Sample Report |
|

Explore online costs by MS-DRG, medical service, routine service, or department
More Information | Sample Report
More Information | Sample Report
Clinical Services
|
|
Joint Commission Accreditation
- Accreditation status licensed from The Joint Commission
- Last updated 04/01/2022 / Definitions and Terms of Use
- Current Status: 08/31/2019 - Accreditation with Full Standards Compliance

Drill down to more granular utilization statistics for ICD diagnoses and procedures
More Information | Sample Report
More Information | Sample Report

Use coding indicators and comparative data to identify areas for improvement
More Information | Sample Report
More Information | Sample Report
Inpatient Utilization Statistics by Medical Service
Number Medicare Inpatients |
Average Length of Stay |
Average Charges |
Medicare Case Mix Index (CMI) |
|
---|---|---|---|---|
Cardiology | 155 | 4.85 | $19,093 | 1.1958 |
Cardiovascular Surgery | 25 | 5.52 | $75,338 | 3.5732 |
Medicine | 498 | 5.59 | $20,331 | 1.3092 |
Neurology | 106 | 5.08 | $21,421 | 1.2463 |
Oncology | 33 | 5.03 | $18,725 | 1.6930 |
Orthopedic Surgery | 201 | 3.63 | $29,528 | 2.2252 |
Orthopedics | 37 | 5.81 | $19,442 | 1.1193 |
Psychiatry | 63 | 11.46 | $13,200 | 1.1994 |
Pulmonology | 495 | 7.01 | $28,868 | 1.8105 |
Surgery | 149 | 8.62 | $44,491 | 3.1099 |
Urology | 140 | 5.13 | $15,559 | 1.1583 |
Vascular Surgery | 47 | 3.49 | $31,696 | 1.7556 |
Total | 1,957 | 6.00 | $25,616 | 1.6851 |

Build color coded maps based on more detailed Patient Origin data
More Information | Sample Report
More Information | Sample Report
Inpatient Origin for Top 3 Zip Codes
- Medicare Hospital Market Service Area File for calendar year ending 12/31/2020 / Definitions
ZIP Code of Residence | Discharges | Days of Care | Charges | Discharges Inc/(Dec) | Market Share |
---|---|---|---|---|---|
35976 | 527 | 3,297 | $12,833,070 | -11.1% | 55.8% |
35950 | 522 | 2,629 | $11,568,911 | -6.1% | 63.5% |
35957 | 443 | 2,430 | $10,432,628 | -11.6% | 55.4% |
Outpatient Utilization Statistics by APC
APC Number |
APC Description | Number Patient Claims |
Average Charge |
Average Cost |
---|---|---|---|---|
5025 | Level 5 Type A ED Visits | 2,063 | $418 | $141 |
5024 | Level 4 Type A ED Visits | 2,486 | $275 | $93 |
1490 | Inj pembrolizumab | 69 | $55 | $9 |
5523 | Level 3 Imaging without Contrast | 2,852 | $1,239 | $86 |
5183 | Level 3 Vascular Procedures | 211 | $7,401 | $1,706 |
5193 | Level 3 Endovascular Procedures | 58 | $16,777 | $3,189 |
5114 | Level 4 Musculoskeletal Procedures | 92 | $1,363 | $321 |
9272 | Inj, denosumab | 423 | $38 | $7 |
9453 | Injection, nivolumab | 43 | $47 | $8 |
5194 | Level 4 Endovascular Procedures | 31 | $23,145 | $4,251 |
5522 | Level 2 Imaging without Contrast | 4,272 | $885 | $61 |
5052 | Level 2 Skin Procedures | 683 | $1,475 | $348 |
5693 | Level 3 Drug Administration | 1,936 | $304 | $75 |
5361 | Level 1 Laparoscopy and Related Services | 95 | $1,820 | $429 |
9186 | Inj., rituximab, 10 mg | 48 | $121 | $21 |
5593 | Level 3 Nuclear Medicine and Related Services | 324 | $2,129 | $148 |
5572 | Level 2 Imaging with Contrast | 967 | $2,202 | $153 |
5312 | Level 2 Lower GI Procedures | 311 | $1,873 | $441 |
9492 | Inj., durvalumab, 10 mg | 33 | $138 | $24 |
5301 | Level 1 Upper GI Procedures | 396 | $1,564 | $368 |
Beds and Patient Days by Unit
Available Beds | Inpatient Days | |
---|---|---|
HOSPITAL (including swing beds) |
||
Routine Services | 172 | 28,626 |
Special Care | 20 | 6,185 |
Nursery | 2,580 | |
Total Hospital | 192 | 37,391 |

Use a five-year view of Profile statistics to spot trends
More Information | Sample Report
More Information | Sample Report
Financial Statistics
$ | % | |
---|---|---|
Gross Patient Revenue | 96.4 | |
Non-Patient Revenue | 3.6 | |
Total Revenue | ||
Net Income (or Loss) | 3.7 |